MedTrace Logo

In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365

NCT07208227 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2025-10-06

No results posted yet for this study

Summary

Tolerance and efficacy study of an anti aging cream on 44 subjects aged between 45 and 65 years, with sensitive skin and deep wrinkles. This study is conducted as a national, monocentric, non-randomized open trial.

Planning of the visits:

* Visit 1: Inclusion (Day 1)
* Visit 2: Intermediate visit (Day 29), a window of +48 hours is allowed
* Visit 3: End of study (Day 57), a window of +72 hours is allowed The maximum duration of participation for a subject is 60 days.

Conditions

  • Healthy
  • Sensitive Skin
  • Deep Wrinkles

Interventions

OTHER

Face Cream RV4983A LA3365

Cosmetic face cream product applied once a day on face, neck and neckline.

Sponsors & Collaborators

  • Pierre Fabre Dermo Cosmetique

    lead INDUSTRY

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-27
Primary Completion
2022-02-07
Completion
2022-02-07

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07208227 on ClinicalTrials.gov